Concord Biotech Ltd Financials Statements

    Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

    Consolidate
    Standalone
    Financial Year
    Jun '25
    Mar '25
    Dec '24
    Sep '24
    Jun '24
    Total Qtr Revenue cr
    217.67
    439.27
    258.95
    320.21
    226.11
    Other Income Qtr Cr13.689.3814.7310.0310.31
    Operating Revenues Qtr203.99429.88244.22310.18215.80
    Loading chart...
    Operating Expenses Qtr
    142.59
    239.46
    146.27
    173.50
    134.52
    Operating Profit Qtr
    61.40
    190.42
    97.95
    136.68
    81.28
    EBITDA Qtr Cr
    75.07
    199.81
    112.68
    146.70
    91.59
    Depreciation Qtr
    17.78
    14.62
    13.26
    13.31
    13.18
    Net Profit Qtr
    44.06
    140.39
    75.92
    95.74
    59.59
    Basic EPS Qtr
    4.21
    13.42
    7.26
    9.15
    5.70
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -